TOP1 and cancer: Top1 inhibitors have been widely used in cancer therapies, most of them cause cytotoxicity by trapping the cross-linked DNA-Top1 intermediate, thus interfering with processes such as DNA replication and transcription (Thomas and Pommier 2019).